Enhancing drug discovery using new techniques for detecting weak binding molecules
Improving Fragment Based Drug Discovery and the Development of Tools for Chemical Biology through Nanoscale Encapsulation and NMR Spectroscopy
['FUNDING_R01'] · TEXAS A&M AGRILIFE RESEARCH · NIH-11094570
This study is working on a new way to find potential new medicines by using advanced techniques to spot small interactions between tiny molecules and proteins, which could help discover drugs that might have been missed before, making the process of developing new treatments better and more efficient.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | TEXAS A&M AGRILIFE RESEARCH (nih funded) |
| Locations | 1 site (College Station, UNITED STATES) |
| Trial ID | NIH-11094570 on ClinicalTrials.gov |
What this research studies
This research focuses on improving the process of drug discovery by developing new methods to detect weak binding interactions between small molecules and proteins. It aims to address the limitations of traditional high-throughput screening, which can be costly and inefficient. By utilizing nanoscale encapsulation and NMR spectroscopy, the study seeks to create a more effective way to identify promising drug candidates, particularly those that may have been overlooked due to their weak binding properties. This innovative approach could lead to more successful drug development in the early phases.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with conditions that could benefit from new drug therapies targeting weak binding interactions.
Not a fit: Patients who are not seeking new drug therapies or those with conditions that are not addressed by small molecule drugs may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the discovery of new and more effective small molecule drugs for various diseases.
How similar studies have performed: While fragment-based drug discovery has been explored before, this specific approach utilizing nanoscale encapsulation and NMR spectroscopy is innovative and has not been widely tested.
Where this research is happening
College Station, UNITED STATES
- TEXAS A&M AGRILIFE RESEARCH — College Station, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: WAND, A. JOSHUA — TEXAS A&M AGRILIFE RESEARCH
- Study coordinator: WAND, A. JOSHUA
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.